MHRA-101521-PIP01-24

Key Facts

Active Substance
Active Substance:
  • Derivative of 6-(piperidine-1-carbonyl)pyridine-3-ol
Invented Name
Not yet available
PIP Number MHRA-101521-PIP01-24
Pharmaceutical form(s)
  • Film-coated tablet
  • Age appropriate oral solid dosage form
Therapeutic area
Therapeutic area:
  • Uro-Nephrology
Conditions / Indications
Conditions / Indications:
  • Treatment of glomerulonephritis and nephrotic syndrome
Route(s) of administration
Route(s) of administration:
  • Oral use
PIP applicant
Decision Type
Decision Type
P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s)
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):Derivative of 6-(piperidine-1-carbonyl)pyridine-3-ol.pdf
Published Date 28/11/2024